Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Eckuity Moves to Disrupt Manufacturing in the $300 Billion Biologics Market with an Investment in Mobius Biomedical
Life Sciences Times
-
March 28, 2022
0
Venture Capital
Schrocken Strengthens the Executive Team and Board as It Gears up for US Launch and Raise Series A Funding Round
Life Sciences Times
-
March 25, 2022
0
Venture Capital
Motorola Solutions Acquires TETRA Ireland Communications, the Provider of Ireland’s National Digital Radio Service
Life Sciences Times
-
March 23, 2022
0
Venture Capital
Ocelot Bio Closes $36 Million Series A Financing, Appoints Katherine Vega Stultz as President and Chief Executive Officer
Life Sciences Times
-
March 23, 2022
0
Venture Capital
TemperPack Accelerates Growth with $140 Million in New Funding, Led by Goldman Sachs Asset Management
Life Sciences Times
-
March 22, 2022
0
Venture Capital
ITM Receives EUR 33 Million Equity Investment to Advance Precision Oncology Pipeline of Targeted Radiopharmaceuticals
Life Sciences Times
-
March 22, 2022
0
Venture Capital
MedTex Ventures Raises $50 Million to Back Early-Stage Medical Devices
Life Sciences Times
-
March 17, 2022
0
Venture Capital
Deepcell Raises $73 Million Series B Round to Advance Its AI-Powered Single Cell Analysis Platform
Life Sciences Times
-
March 17, 2022
0
Venture Capital
Frazier Life Sciences Closes $987 Million Venture Fund to Invest in Companies Developing Novel Biopharmaceuticals
Life Sciences Times
-
March 16, 2022
0
Venture Capital
KayoThera, Inc. Raises $8 Million in Series A Financing Led by Accelerator Life Science Partners to Develop Novel Cancer Immunotherapeutics
Life Sciences Times
-
March 16, 2022
0
Venture Capital
BioCoach Reaches $100 Million Valuation for Its Innovative Approach to Digital Health Solutions
Life Sciences Times
-
March 16, 2022
0
Venture Capital
metaMe Health Raises $2.2 Million to Bring Its IBS Solution to Market
Life Sciences Times
-
March 15, 2022
0
1
...
81
82
83
...
115
Page 82 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026